|
|
|
|
|
adMare BioInnovations Portfolio Company SoundBite Receives FDA 510(k) Clearance
|
Vancouver, BC, February 10, 2020--SoundBite Medical Solutions Inc.(SBMS), an adMare BioInnovations portfolio company, announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SoundBite™ Crossing System, a unique active wire technology for use in the treatment of peripheral chronic total occlusions (CTOs).
|
|
|
|
|
|
|
|
|
|